628
Views
15
CrossRef citations to date
0
Altmetric
Drug Profile

The relationship between allergen immunotherapy and omalizumab for treating asthma

, , , , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Corrado Pelaia, Alessandro Vatrella, Nicola Lombardo, Rosa Terracciano, Paolo Navalesi, Rocco Savino & Girolamo Pelaia. (2018) Biological mechanisms underlying the clinical effects of allergen-specific immunotherapy in asthmatic children. Expert Opinion on Biological Therapy 18:2, pages 197-204.
Read now
Santiago Quirce, Paloma Campo, Javier Domínguez-Ortega, Mar Fernández-Nieto, Elisa Gómez-Torrijos, Ana Martínez-Arcediano, Pilar Mur & Julio Delgado. (2017) New developments in work-related asthma. Expert Review of Clinical Immunology 13:3, pages 271-281.
Read now

Articles from other publishers (13)

M. Tabardel, E. Clark, P. Demoly & D. Caimmi. (2022) Les anticorps monoclonaux à disposition des allergologues pour traiter l’asthme sévère. Revue Française d'Allergologie 62:6, pages 572-577.
Crossref
Lin Yang & Rongfei Zhu. (2021) Allergen Preparation in AIT, Now and in the Future. Current Treatment Options in Allergy 8:2, pages 120-132.
Crossref
Giacomo Malipiero, Giulio Melone, Francesca Puggioni, Ruby Pawankar, Enrico Heffler & Giovanni Paoletti. (2021) Allergen immunotherapy and biologics in respiratory allergy: friends or foes?. Current Opinion in Allergy & Clinical Immunology 21:1, pages 16-23.
Crossref
Stacy Gelhaus Wendell, Hao Fan & Cheng Zhang. (2019) G Protein–Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action. Pharmacological Reviews 72:1, pages 1-49.
Crossref
Gregorio Gomez. (2019) Current Strategies to Inhibit High Affinity FcεRI-Mediated Signaling for the Treatment of Allergic Disease. Frontiers in Immunology 10.
Crossref
C. Carrier, P. Demoly & D. Caimmi. (2019) Omalizumab et immunothérapie allergénique : cas clinique et revue de la littérature. Revue des Maladies Respiratoires 36:2, pages 191-196.
Crossref
Carlo Lombardi, Giorgio W. Canonica & Giovanni Passalacqua. (2018) Allergen immunotherapy as add-on to biologic agents. Current Opinion in Allergy & Clinical Immunology 18:6, pages 502-508.
Crossref
Mohana Rajakulendran, Elizabeth Huiwen ThamJian Yi SohHP Van Bever. (2018) Novel strategies in immunotherapy for allergic diseases. Asia Pacific Allergy 8:2.
Crossref
Corrado Pelaia, Cecilia Calabrese, Rosa Terracciano, Francesco de Blasio, Alessandro Vatrella & Girolamo Pelaia. (2018) Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness. Therapeutic Advances in Respiratory Disease 12, pages 175346661881019.
Crossref
Pascal Demoly, Melina Makatsori, Thomas B. Casale & Moises A. Calderon. (2017) The Potential Role of Allergen Immunotherapy in Stepping Down Asthma Treatment. The Journal of Allergy and Clinical Immunology: In Practice 5:3, pages 640-648.
Crossref
Sophia Tsabouri, Antigoni Mavroudi, Gavriela Feketea & George V. Guibas. (2017) Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in Children. Frontiers in Pediatrics 5.
Crossref
Matteo FerrandoDiego BagnascoGilda VarricchiStefano BernardiAlice BragantiniGiovanni PassalacquaGiorgio Walter Canonica. (2017) Personalized Medicine in Allergy. Allergy, Asthma & Immunology Research 9:1, pages 15.
Crossref
Nadine Mokhallati & Theresa W. Guilbert. (2016) Moving towards precision care for childhood asthma. Current Opinion in Pediatrics 28:3, pages 331-338.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.